GEXVal CTO to Present at IIBMP2025
wpmaster
GEXVal Inc.
August 21, 2025
GEXVal CTO to Present at Informatics In Biology, Medicine and Pharmacology (IIBMP2025)
GEXVal Inc. (President and CEO: Juran Kato, PhD; Location: Fujisawa, Kanagawa, Japan, hereinafter “GEXVal”) is pleased to announce that Chief Technology Officer Dr. Yusuke Nakayama will present at the Informatics In Biology, Medicine and Pharmacology 2025, delivering a presentation titled "Data-Driven Drug Discovery Using Graph Neural Networks: A Multi-layered Approach for COVID-19 Therapeutic Candidate Discovery."
[Event Overview]
This event transcends the boundaries of bioinformatics, aiming to create new insights through the convergence of diverse fields including life sciences, medicine, pharmaceutical sciences, engineering, and information science. The meeting features keynote lectures by leading domestic and international researchers and poster presentations through diverse programs, creating opportunities for academic exchange and fostering new collaborative research initiatives.
**Presentation Details**
|
Conference |
Informatics In Biology, Medicine and Pharmacology 2025 (IIBMP2025) |
|
Date |
September 3 - 5, 2025 |
|
Venue |
Toyota Auditorium 1F Lobby & Foyer (PO-009) |
|
URL |
Informatics In Biology, Medicine and Pharmacology 2025 (IIBMP2025) |
[About IIBMP]
The Informatics In Biology, Medicine and Pharmacology (IIBMP) is Japan's premier bioinformatics conference organized by the Japanese Society for Bioinformatics (JSBi). As an affiliated regional group of the International Society for Computational Biology (ISCB) and member of the Association of Asian Societies for Bioinformatics (AASBi), JSBi has been at the forefront of bioinformatics research and education since 1999. The conference serves as a critical platform for advancing computational biology research in Asia, bringing together leading researchers, industry professionals, and academic institutions to explore cutting-edge developments in data-driven life sciences and therapeutic discovery.
[About GEXVal]
GEXVal strives to create and develop innovative pharmaceuticals for unmet medical needs, ensuring Treatment Reaches the Unreached with focus on rare diseases and underserved medical conditions. By leveraging our proprietary AI-powered pharmacoinformatics technology, we illuminate paths to breakthrough therapies, identifying hidden potential in drug candidates to deliver life-changing medicines that bring new hope to patients and their families.
For further information:
Head of Corporate Office
Atsushi Sugizaki
info@gexval.com
